Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Carien L. Creutzberg"'
Autor:
Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J Jobsen, Mariel Brinkhuis, Suzan Roothaan, Ina Jurgenliemk-Schulz, Ludy C H W Lutgens, Remi A Nout, Elzbieta M van der Steen-Banasik, Stephanie M de Boer, Melanie E Powell, Naveena Singh, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Vincent T H B M Smit, Carien L Creutzberg, Nanda Horeweg, Viktor H Koelzer, Tjalling Bosse
Publikováno v:
The Lancet Digital Health, 5(2), e71-e82. Lancet Publishing Group
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
Background: Endometrial cancer can be molecularly classified into POLEmut, mismatch repair deficient (MMRd), p53 abnormal (p53abn), and no specific molecular profile (NSMP) subgroups. We aimed to develop an interpretable deep learning pipeline for wh
Autor:
Mary McCormack, Carien L. Creutzberg, V. Do, Bastiaan G Wortman, Melanie E Powell, C. Post, Karen Whitmarsh, Marie Helene Baron, Linda Mileshkin, Ina M. Jürgenliemk-Schulz, Christine Haie-Meder, Eleftheria Astreinidou, Dionyssios Katsaros, Susan Brooks, Romerai D'Amico, Anthony Fyles, Stephanie M. de Boer, Ludy C.H.W. Lutgens, Hein Putter, Henry C Kitchener, Pearly Khaw, Remi A. Nout, Hans W. Nijman, Paul Bessette
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 112(2), 390-399. Elsevier Inc.
International Journal of Radiation Oncology, Biology, Physics, 112(2), 390-399. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology Biology Physics, 112(2), 390-399. Elsevier Science
International Journal of Radiation Oncology-Biology-Physics, 112(2), 390-399. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 112(2), 390-399. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology Biology Physics, 112(2), 390-399. Elsevier Science
International Journal of Radiation Oncology-Biology-Physics, 112(2), 390-399. ELSEVIER SCIENCE INC
Purpose: Radiation therapy techniques have developed from 3-dimensional conformal radiation therapy (3DCRT) to intensity modulated radiation therapy (IMRT), with better sparing of the surrounding normal tissues. The current analysis aimed to investig
Autor:
David Nunns, Hein Putter, Derek Cruickshank, V Asher, Jayanthi S. Lea, Charles F Levenback, Timothy J. Duncan, Paul DiSilvestro, Jiri Bouda, Ming Y. Tjiong, Mario M. Leitao, Ingo B. Runnebaum, Martin Widschwendter, Geertruida H. de Bock, Kalyan Dhar, Joanne A. de Hullu, Pernille Tine Jensen, David Cibula, Nicola M. Spirtos, Preben Kjølhede, Willemien J. van Driel, Brigitte F. M. Slangen, Diane Provencher, Helena C. van Doorn, Ralph H Hermans, Christer Borgfeldt, Ate G J van der Zee, Eleonora B.L. van Dorst, Katja N. Gaarenstroom, Bradley J. Monk, Brynhildur Eyjolfsdottir, Ranjit Manchanda, Robert S. Mannel, Katharina Kieser, Aarti Sharma, Brian Slomovitz, Krishnansu S. Tewari, Jo Bailey, Linda Van Le, Maaike H. M. Oonk, David Nugent, David M. O'Malley, Karl Tamussino, Jacobus van der Velden, Patricia Ellis, Al Covens, Connie Palle, Stephen Attard-Montalto, David Luesley, Melissa A. Geller, Cathrine M Holland, Margareta Lood, Par Persson, D. Boll, Mats Brännström, Daniel H Tobias, Ignace Vergote, Peter Baldwin, Carien L. Creutzberg
Publikováno v:
Oonk, M H M, Slomovitz, B, Baldwin, P J W, van Doorn, H C, van der Velden, J, de Hullu, J A, Gaarenstroom, K N, Slangen, B F M, Vergote, I, Brännström, M, van Dorst, E B L, van Driel, W J, Hermans, R H, Nunns, D, Widschwendter, M, Nugent, D, Holland, C M, Sharma, A, DiSilvestro, P A, Mannel, R, Boll, D, Cibula, D, Covens, A, Provencher, D, Runnebaum, I B, Luesley, D, Ellis, P, Duncan, T J, Tjiong, M Y, Cruickshank, D J, Kjølhede, P, Levenback, C F, Bouda, J, Kieser, K E, Palle, C, Spirtos, N M, O'Malley, D M, Leitao, M M, Geller, M A, Dhar, K, Asher, V, Tamussino, K, Tobias, D H, Borgfeldt, C, Lea, J S, Bailey, J, Lood, M, Eyjolfsdottir, B, Attard-Montalto, S, Tewari, K S, Manchanda, R, Jensen, P T, Persson, P, Van Le, L, Putter, H, de Bock, G H, Monk, B J, Creutzberg, C L & van der Zee, A G J 2021, ' Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node : Results of GROINSS-V II ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 32, pp. 3623-3632 . https://doi.org/10.1200/JCO.21.00006
Journal of Clinical Oncology, 39(32), 3623-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 39(32), 3623-3632. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 32, pp. 3623-3632
Journal of Clinical Oncology, 39, 3623-3632
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3623-3632. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3623-3632. American Society of Clinical Oncology
Journal of clinical oncology, 39(32), 3623-3632. American Society of Clinical Oncology
Journal of Clinical Oncology, 39(32), 3623-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 39(32), 3623-3632. American Society of Clinical Oncology
Journal of Clinical Oncology, 39, 32, pp. 3623-3632
Journal of Clinical Oncology, 39, 3623-3632
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3623-3632. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(32), 3623-3632. American Society of Clinical Oncology
Journal of clinical oncology, 39(32), 3623-3632. American Society of Clinical Oncology
PURPOSE The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients with a metastatic sen
Autor:
Ina M. Jürgenliemk-Schulz, Elsbieta M. van der Steen-Banasik, Remi A. Nout, Jannet C. Beukema, Max Peters, Baukelien van Triest, Petronella O. Witteveen, Carien L. Creutzberg, Joanne A. de Hullu, Ludy C.H.W. Lutgens, Jacobus van der Velden, Henrike Westerveld, Marnix J.A. Rasing, An Snyers
Publikováno v:
Gynecologic Oncology, 163(1), 117-124. Academic Press
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 163(1), 117-124. Academic Press Inc.
Gynecologic Oncology, 163, 1, pp. 117-124
Gynecologic Oncology, 163, 117-124
Gynecologic Oncology, 163(1), 117-124. ACADEMIC PRESS INC ELSEVIER SCIENCE
Objective. To evaluate feasibility of chemoradiation as alternative for extensive surgery in patients with locally advanced vulvar cancer and to report on locoregional control, toxicity and survival. Methods. In a multicenter, prospective phase II tr
Autor:
Cornelis D. de Kroon, Annerie Slot, Jannet C. Beukema, Tanja C. Stam, Judith R. Kroep, Hetty A. van den Berg, Ina M. Jürgenliemk-Schulz, Cathalijne C.B. Post, Jan Willem M. Mens, Ludy C.H.W. Lutgens, F. Koppe, Marie A.D. Haverkort, Ellen M.A. Roeloffzen, An Snyers, Carien L. Creutzberg, Eva E. Schaake, Anne M. Stiggelbout, Hans W. Nijman
Publikováno v:
Gynecologic Oncology, 161(3), 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Gynecologic Oncology, 161(3), 727-733. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 161(3), 727-733. Academic Press
Gynecologic Oncology, 161, 727-733
Gynecologic Oncology, 161(3), 727-733. Elsevier Science
Gynecologic Oncology, 161, 3, pp. 727-733
Background. Decision making regarding adjuvant therapy for high-risk endometrial cancer is complex. The aim of this study was to determine patients' and clinicians' minimally desired survival benefit to choose chemoradiotherapy over radiotherapy alon
Autor:
Lisa Vermij, Alicia Léon-Castillo, Naveena Singh, Melanie E. Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Leary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, N. Horeweg, S.M. de Boer, C.L. Creutzberg, T. Bosse, V.T.H.B.M. Smit, J. Kroep, R.A. Nout, H.W. Nijman, M. de Bruyn, M.E. Powell, N. Singh, H.C. Kitchener, E. Crosbie, R. Edmondson, D.N. Church, A. Leary, L. Mileshkin, P.M. Pollock, H. MacKay
Publikováno v:
Modern Pathology, 35(10), 1475-1483. SPRINGERNATURE
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Modern Pathology, 35(10), 1475-1483. Nature Publishing Group
TransPORTEC consortium 2022, ' p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial ', Modern Pathology . https://doi.org/10.1038/s41379-022-01102-x
Modern Pathology. Nature Publishing Group
Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and the most likely to benefit from adjuvant chemo(radio)therapy. P53abn EC ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::081e838f95f1846415ec67f616f3afc4
https://hdl.handle.net/1887/3505651
https://hdl.handle.net/1887/3505651
Autor:
Ji Q. Wu, Nanda Horeweg, Marco de Bruyn, Remi A. Nout, Ina M. Jürgenliemk-Schulz, Ludy C. H. W. Lutgens, Jan J. Jobsen, Elzbieta M. van der Steen-Banasik, Hans W. Nijman, Vincent T. H. B. M. Smit, Tjalling Bosse, Carien L. Creutzberg, Viktor H. Koelzer
Publikováno v:
Nature Machine Intelligence, 4(5), 436-444. NATURE PORTFOLIO
Nature Machine Intelligence, 4(5), 436-444. Nature Publishing Group
Nature Machine Intelligence, 4. NATURE PORTFOLIO
Nature Machine Intelligence, 4(5), 436-444. Springer Nature Switzerland AG
Nature Machine Intelligence, 4(5), 436-444. Nature Publishing Group
Nature Machine Intelligence, 4. NATURE PORTFOLIO
Nature Machine Intelligence, 4(5), 436-444. Springer Nature Switzerland AG
Randomized controlled trials (RCTs) are considered as the gold standard for testing causal hypotheses in the clinical domain. However, the investigation of prognostic variables of patient outcome in a hypothesized cause-effect route is not feasible u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::625e6b79285fb3159ff006c245ddd016
http://hdl.handle.net/1887/3561426
http://hdl.handle.net/1887/3561426
Autor:
Nanda, Horeweg, Hagma H, Workel, Dominik, Loiero, David N, Church, Lisa, Vermij, Alicia, Léon-Castillo, Ricki T, Krog, Stephanie M, de Boer, Remi A, Nout, Melanie E, Powell, Linda R, Mileshkin, Helen, MacKay, Alexandra, Leary, Naveena, Singh, Ina M, Jürgenliemk-Schulz, Vincent T H B M, Smit, Carien L, Creutzberg, Viktor H, Koelzer, Hans W, Nijman, Tjalling, Bosse, Marco, de Bruyn
Publikováno v:
Nature Communications, 13(1). NATURE PORTFOLIO
Nature Communications, 13(1):1373. Nature Publishing Group
Nature Communications, 13(1):1373. Nature Publishing Group
B-cells play a key role in cancer suppression, particularly when aggregated in tertiary lymphoid structures (TLS). Here, we investigate the role of B-cells and TLS in endometrial cancer (EC). Single cell RNA-sequencing of B-cells shows presence of na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc451013e20a5bae0c2ad465678c4abe
http://hdl.handle.net/1887/3281916
http://hdl.handle.net/1887/3281916
Autor:
Nanda Horeweg, Stefan Kommoss, Ludy C.H.W. Lutgens, Katrien Vandecasteele, Marlies E. Nowee, Remi A. Nout, C. Gillham, Bastiaan G Wortman, F. Koppe, Hetty A. van den Berg, Tjalling Bosse, David Cibula, Karen W Verhoeven-Adema, Annerie Slot, Hein Putter, Cyrus Chargari, Ina M. Jürgenliemk-Schulz, Veronique L M A Coen, Aleida G Zwanenburg, Hans W. Nijman, Carien L. Creutzberg, Elzbieta van der Steen-Banasik, Tanja C. Stam, G Henrieke Westerveld, Anne Sophie V M van den Heerik, Wilbert B. van den Hout, Jan Willem M. Mens, An Snyers, Moritz Hamann, Stefan Bijmolt
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020(30), 2002-2007. BMJ Publishing Group
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS
BackgroundVaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, t
Autor:
Renaud Mazeron, Jacob Christian Lindegaard, Carien L. Creutzberg, Alina Sturdza, Zdenko van Kesteren, Henrike Westerveld, Bradley R. Pieters, Lars Fokdal, Nicole Nesvacil, Cyrus Chargari, Maximilian Schmid, Remi A. Nout
Publikováno v:
Westerveld, H, Schmid, M P, Nout, R A, Chargari, C, Pieters, B R, Creutzberg, C L, Sturdza, A, Lindegaard, J C, van Kesteren, Z, Mazeron, R, Nesvacil, N & Fokdal, L U 2021, ' Image-guided adaptive brachytherapy (Igabt) for primary vaginal cancer : Results of the international multicenter retroembrave cohort study ', Cancers, vol. 13, no. 6, 1459 . https://doi.org/10.3390/cancers13061459
Cancers, Vol 13, Iss 1459, p 1459 (2021)
Cancers, 13(6). MDPI
Cancers, 13(6):1459. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1459, p 1459 (2021)
Cancers, 13(6). MDPI
Cancers, 13(6):1459. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 13
Issue 6
Purpose: This study assessed outcomes following the nowadays standing treatment for primary vaginal cancer with radio(chemo)therapy and image-guided adaptive brachytherapy (IGABT) in a multicenter patient cohort. Methods: Patients treated with comput
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc1b1094652fbefbbb6478216648aa7
https://hdl.handle.net/1887/3278723
https://hdl.handle.net/1887/3278723